Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net loss	$ (2,976)	$ (99,925)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	1,196	1,816
Amortization of deferred financing costs and debt discount	9,794	12,463
Interest expense on 5.75% Convertible Notes paid in shares	1,423
Stock-based compensation expense	804	971
Provision for doubtful accounts	1,685	(1,107)
Periodic lease cost	2,243	2,124
(Earnings) loss on equity investments in joint ventures	1,364	(14)
Distributions from equity investments	3,928	2,681
Contract asset impairment	4,467	5,143
Asset impairment	62	1,766
Trademark impairment	35,053	65,587
Impairment of equity method investment	19,607	26,613
Mark to market adjustment on convertible note	3,590	3,861
Loss (gain) on debt to equity conversions		1,310
Gain on sale of trademarks and other investments	(75,705)	(141)
Income on other equity investment		294
Deferred income tax expense	731	(80)
(Gain) Loss on foreign currency translation	1,570	858
Changes in operating assets and liabilities:
Accounts receivable	4,020	6,927
Other assets – current	4,788	12,173
Other assets	(937)	(1,882)
Deferred revenue	(104)	29
Accounts payable and accrued expenses	(14,902)	(8,836)
Other liabilities	18,722	(2,319)
Net Cash provided by operating activities	20,423	30,312
Cash flows provided by (used in) investing activities:
Purchases of property and equipment	(602)	(626)
Acquisition of trademarks and other investments	(2,358)	(6,001)
Issuance of loan to equity investee	(2,750)
Proceeds from loan to equity investee	2,750
Proceeds from sale of trademarks and investments	80,101	18,695
Net cash provided by investing activities	77,141	12,068
Cash flows (used in) financing activities:
Payment of long-term debt	(96,012)	(41,171)
Proceeds from Paycheck Protection Program Loan	1,307
Distributions to non-controlling interests	(6,765)	(12,018)
Distributions to redeemable non-controlling interests	(8,785)	(461)
Cost of shares repurchased on vesting of restricted stock	(84)	(189)
Net cash (used in) financing activities	(110,339)	(53,839)
Effect of exchange rate changes on cash and restricted cash	541	235
Net increase (decrease) in cash and cash equivalents, and restricted cash	(12,234)	(11,224)
Cash, cash equivalents, and restricted cash, beginning of period	71,411	82,635
Cash, cash equivalents, and restricted cash, end of period	59,177	71,411
Cash paid during the period:
Income taxes (net of refunds received)	(1,615)	(8,704)
Interest	35,217	45,066
Non-cash investing and financing activities:
Non-cash additions to operating lease assets	$ 288	10,462
Non-cash repurchase of China JV equity		1,265
Shares issued upon conversion of debt to equity		$ 6,225